Clinical Trials Logo

Clinical Trial Summary

This study will explore scientists opinions and practices regarding the use of population descriptors (e.g., race, ethnicity, ancestry, geography and nationality) to describe a research study population. It will collect genetic researchers opinions, understandings and experiences studying human genetics and genetic variation.

Scientists who are a principal investigator or co-principal investigator n a human genetic or genomic study of a common disease with at least preliminary data that uses population descriptors may be eligible for the study.

Participants are asked to think about their study populations and how they are described in their research. They participate in two audio-taped semi-structured interviews that last from about 90 to 120 minutes. They may also participate in one or both of the following optional study components:

- A third semi-structured interview that explores implementing a new method of describing study populations in data analysis.

- 2 to 3 days of lab observation, in which a member of the study research team meets the lab members, observes daily activities and attends lab meetings.


Clinical Trial Description

The usefulness of social and political population labels, including those based on race, ethnicity, geographic location, ancestry, and nationality, in science and medicine is a topic of heated debate. The discussion is significant not only for defining rigorous scientific study designs, but for influencing how scientists and the broader society conceptualize, discuss, and react to human difference. Misuse of population descriptors in genetic and genomic research has the potential to perpetuate misinformation, stigmatize certain groups and simplify the complex relationships between individual identity, genetics, and health. With such potential harms in mind, National Institutes of Health guidelines to use the Office of Management and Budget categories of race and ethnicity to monitor inclusion in clinical trials and evaluate potential differences in the safety and efficacy of interventions have been questioned. As increasing attention is given to the implications of human genetic variation on disease and health, actively engaging with scientists may help to identify a lexicon for discussing human genetic variation that is scientifically sound and socially and politically meaningful. We aim to conduct a pilot qualitative study of genetic researchers, exploring their use of population descriptors in human genetic research, including an experiment in which they have the opportunity to describe and group their study populations in a new way. We use qualitative methods to capture researchers' opinions and practices as they think critically about the use of population labels in their studies. Understanding individual scientists opinions about the strengths and weaknesses of different classifications in various contexts will provide important data to help define and facilitate appropriate use of population descriptors in human genetic research. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00767702
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date September 18, 2008
Completion date August 8, 2012

See also
  Status Clinical Trial Phase
Recruiting NCT05608096 - European Registry for Hemadsorption in Sepsis With the Seraph Filter
Completed NCT02868177 - Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes Phase 2/Phase 3
Completed NCT05564559 - Multifamily Group Psychoeducation for SUD's in Turkey N/A
Enrolling by invitation NCT03337893 - Investigation of Breastfeeding Protection Against Infant Infections and Childhood Diseases N/A
Recruiting NCT03388424 - Quantification of Microbiota in Health and Diseases
Completed NCT03722459 - Novel MRI Sequence- MR Fingerprinting N/A
Completed NCT03295123 - Outcome of Children Born After Pregnancy Denial
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Not yet recruiting NCT05853991 - Effects of Touch on Brain Connectivity and Metabolic Biomarkers in Preterm Infants N/A
Active, not recruiting NCT02195778 - Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment. N/A
Recruiting NCT06081452 - Public Survey on Breath Testing for Health and Disease
Recruiting NCT04973774 - A Multi-center Prospective Study of Branch Atheromatous Disease in China
Not yet recruiting NCT04866732 - Physical Activity Program for Cardiac Health Among Older African American Populations N/A
Completed NCT01043133 - Study of Medical Student Use of Templates to Document Outpatient Asthma Care in Electronic Medical Record N/A
Recruiting NCT01317979 - Asian Diabetes Surgery Study (ADSS): Clinical Predictor for the Success of Metabolic Surgery N/A
Recruiting NCT06036433 - Light Therapy Plus Exercise to Improve Motor, Non-Motor Symptoms and QoL in Parkinson's Disease N/A
Completed NCT05214534 - Contribution of SuPAR for Patients in a Situation of Uncertainty Downstream of Emergencies
Completed NCT05930626 - Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures
Completed NCT04210713 - Neuroimmune Dysfunction in Alcohol Use Disorder Phase 1